Bouquegneau, A., Jouret, F., Seidel, L., BONVOISIN, C., Weekers, L., Ribbens, C., Bruyère, O., Cavalier, E., Delanaye, P., & Malaise, O. (07 March 2025). Trabecular bone score to assess bone microarchitecture in end-stage renal disease patients. Archives of Osteoporosis, 20 (1), 34. doi:10.1007/s11657-025-01519-2 |
Guiot, J., André, B., Potjewijd, J., JACQUERIE, P., Cremers, S., Henket, M., Idoufkir, L., Remacle, C., Tobal, R., GILTAY, L., Moermans, C., GESTER, F., Polese, B., Hamaïdia, M., Struman, I., Louis, E., Malaise, M., de Seny, D., van Paassen, P., ... Njock, M.-S. (2025). Association of fibrotic-related extracellular vesicle microRNAs with lung involvement in systemic sclerosis. European Respiratory Journal, 2400276. doi:10.1183/13993003.00276-2024 |
Guiot, J., Henket, M., GESTER, F., André, B., Ernst, B., Frix, A.-N., Smeets, D., Van Eyndhoven, S., Antoniou, K., Conemans, L., Gote-Schniering, J., Slabbynck, H., Kreuter, M., Sellares, J., Tomos, I., Yang, G., Ribbens, C., Louis, R., Cottin, V., ... Walsh, S. L. F. (24 January 2025). Automated AI-based image analysis for quantification and prediction of interstitial lung disease in systemic sclerosis patients. Respiratory Research, 26 (1), 39. doi:10.1186/s12931-025-03117-9 |
Massenet, T., Potjewijd, J., Tobal, R., GESTER, F., Zanella, D., Henket, M., Njock, M.-S., Dejong, T., Gridelet, G., GILTAY, L., GUISSARD, F., André, B., Ribbens, C., Louis, R., Van Paassen, P., Guiot, J., & Stefanuto, P.-H. (November 2024). Systemic Sclerosis: Can Breathomics help clinicians for ILD management? [Poster presentation]. Breath Biopsy Conference 2024. |
Massenet, T., Patjewijd, J., Tobal, R., GESTER, F., Zanella, D., Henket, M., Njock, M.-S., Dejong, T., Gridelet, G., GILTAY, L., GUISSARD, F., André, B., Ribbens, C., Louis, R., Van Paassen, P., Guiot, J.* , & Stefanuto, P.-H.*. (08 September 2024). SYSTEMIC SCLEROSIS: CAN BREATHOMICS MONITOR INTERSTITIAL LUNG DISEASE? [Poster presentation]. The ERS Congress, Vienne, Austria. * These authors have contributed equally to this work. |
Regnier, C., Mina, M., Chauveheid, F., Ribbens, C., & Malaise, O. (June 2024). Que faire pour prévenir l’ostéoporose ? Entre mythes et réalité scientifique. Revue Médicale de Liège, 79 (5-6), 429 - 435. |
Massenet, T., Potjewijd, J., Tobal, R., GESTER, F., Zanella, D., Henket, M., Njock, M.-S., Dejong, T., Gridelet, G., GILTAY, L., GUISSARD, F., André, B., Ribbens, C., Louis, R., Van Paassen, P., Focant, J.-F., Guiot, J., & Stefanuto, P.-H. (28 May 2024). Tackling the analytical challenges to establish a routine workflow for breathomics research [Paper presentation]. 18th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology (HTC-18), Leuven, Belgium. |
Massenet, T., Potjewijd, J., Tobal, R., GESTER, F., Zanella, D., Henket, M., Njock, M.-S., Dejong, T., Gridelet, G., GILTAY, L., GUISSARD, F., André, B., Ribbens, C., Louis, R., Van Paassen, P., Guiot, J., & Stefanuto, P.-H. (2024). Breathomics to monitor interstitial lung disease associated with systemic sclerosis. ERJ Open Research, 00175-2024. doi:10.1183/23120541.00175-2024 |
Rinkin, C., Malaise, O., CHAUVEHEID, F., GERARD, C., Seidel, L., Malaise, M., & Ribbens, C. (07 May 2024). Optical imaging (HandScan) can identify ultrasound remission in rheumatoid arthritis. BMC Musculoskeletal Disorders, 25 (1), 361. doi:10.1186/s12891-024-07472-4 |
Peters, C.* , Malaise, O.* , Longton, J., André, B., & Ribbens, C. (December 2023). Vignette thérapeutique de l’étudiant. Prise en charge de la goutte. Revue Médicale de Liège, 78 (12), 733 - 739. * These authors have contributed equally to this work. |
JACQUERIE, P., André, B., de Seny, D., Henket, M., GILTAY, L., Ernst, M., Louis, R., Malaise, M., Ribbens, C., & Guiot, J. (03 November 2023). Reproducibility of pulmonary function tests in patients with systemic sclerosis. Scientific Reports, 13 (1), 18960. doi:10.1038/s41598-023-45881-y |
DENIS, A., Frix, A.-N., NGUYEN DANG, D., Malaise, O., DEFOURNY, C., Lovinfosse, P., Corhay, J.-L., GESTER, F., Louis, R., Ribbens, C., & Guiot, J. (November 2023). La pathologie pulmonaire associée à la polyarthrite rhumatoïde. Revue Médicale de Liège, 78 (11), 641-648. |
Malaise, O., Bolland, M., & Ribbens, C. (October 2023). Vignette diagnostique de l’étudiant. Prise en charge diagnostique de l’ostéoporose. Revue Médicale de Liège, 78 (10), 586 - 592. |
Constant, S., André, B., Malaise, O., GESTER, F., Guiot, J., RIBBENS, C., & Von Frenckell, C. (September 2023). USE OF IL-6 RECEPTOR INHIBITOR FOR THE MANAGEMENT OF CORTICO-RESISTANT CRYPTOGENIC ORGANIZING PNEUMONIA [Poster presentation]. Belgian Congress of Rheumatology, Gand, Belgium. |
Guiot, J., Henket, M., Remacle, C., Cambier, M., Struman, I., Winandy, M.-L., Moermans, C., Louis, E., Malaise, M., Ribbens, C., Louis, R., & Njock, M.-S. (15 April 2023). Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. Respiratory Research, 24 (1), 112. doi:10.1186/s12931-023-02413-6 |
Bolland, M., Malaise, O., & Ribbens, C. (April 2023). Une nouveauté dans la prise en charge de l’ostéoporose post-ménopausique à très haut risque fracturaire : le romosozumab (Evenity®), un anticorps monoclonal anti-sclérostine. Revue Médicale de Liège, 78 (4), 239 - 244. |
Malaise, O., André, C., Van Durme, C., Seidel, L., Schleich, F., Louis, R., Malaise, M., & Ribbens, C. (20 March 2023). Lung Function Impairment, Associating Hyperinflation with Impaired Diffusion Capacity and Transfer Coefficient, Is a Risk Factor for Hip Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine, 12 (6), 2383. doi:10.3390/jcm12062383 |
MALAISE, M., CHAPELIER, N., DEWAEL, T., LEONORI, L., LEROY, M., Mailleux, E., André, B., Halleux, S., KAISER, M.-J., MALAISE, O., RIBBENS, C., RINKIN, C., VON FRENCKELL, C., & VOLDERS, A. (May 2020). Une révolution thérapeutique en rhumatologie : oui, mais… Revue Médicale de Liège, 75 (5-6), 369-375. |
Gendebien, Z., VON FRENCKELL, C., RIBBENS, C., ANDRE, B., THYS, M., GANGOLF, M., SEIDEL, L., Malaise, M., & MALAISE, O. (2020). Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments. Annals of the Rheumatic Diseases. doi:10.1136/annrheumdis-2020-218244 |
Varkas, G., RIBBENS, C., Louis, E., Van den Bosch, F., Lories, R., Vermeire, S., Elewaut, D., & De Vos, M. (2019). Expert consensus: practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathies. Alimentary Pharmacology and Therapeutics, 50 (11-12), 1204-1213. doi:10.1111/apt.15519 |
DE SENY, D., Sharif, M., Fillet, M., COBRAIVILLE, G., Meuwis, M.-A., Marée, R., HAUZEUR, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., Kirwan, J., Ribbens, C., & Malaise, M. (2011). Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Annals of the Rheumatic Diseases, 70 (6), 1144-52. doi:10.1136/ard.2010.135541 |
De Seny, D., Ribbens, C., Cobraiville, G., Meuwis, M.-A., Marée, R., Geurts, P., Wehenkel, L., Louis, E., Merville, M.-P., Fillet, M., & Malaise, M. (2009). Protéomique par SELDI-TOF-MS des maladies inflammatoires articulaires: identification des protéines S100 comme protéines d'intérêt. Revue Médicale de Liège, 64 (Spec No), 29-35. |
Vander Cruyssen, B., RIBBENS, C., Boonen, A., Mielants, H., de Vlam, K., Lenaerts, J., Steinfeld, S., Van den Bosch, F., Dewulf, L., & Vastesaeger, N. (August 2007). The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Annals of the Rheumatic Diseases, 66 (8), 1072-7. doi:10.1136/ard.2006.064543 |
De Seny, D.* , Fillet, M.* , Meuwis, M.-A., Geurts, P., Lutteri, L., Ribbens, C., Bours, V., Wehenkel, L., Piette, J., Malaise, M., & Merville, M.-P. (2005). Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis and Rheumatism, 52 (12), 3801-12. doi:10.1002/art.21607 * These authors have contributed equally to this work. |
Relic, B., Benoit, V., Franchimont, N., Ribbens, C., Kaiser, M.-J., Gillet, P., Merville, M.-P., Bours, V., & Malaise, M. (2004). 15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. Journal of Biological Chemistry, 279 (21), 399-403. doi:10.1074/jbc.M314118200 |
Ribbens, C., Martin y Porras, M., Franchimont, N., Kaiser, M.-J., Jaspar, J. M., Damas, P., Houssiau, F. A., & Malaise, M. (2002). Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Annals of the Rheumatic Diseases, 61 (2), 161-166. doi:10.1136/ard.61.2.161 |
RIBBENS, C., Dayer, J. M., & Chizzolini, C. (February 2000). CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2- or interleukin-15-driven, contact-dependent, interleukin-1beta production by monocytes. Immunology, 99 (2), 279-86. doi:10.1046/j.1365-2567.2000.00948.x |
Andre, B., Ribbens, C., Kaye, O., & Malaise, M. (April 1997). Les manifestations osteo-articulaires du sujet âgé. Revue Médicale de Liège, 52 (4), 270-277. |
Kaye, O., Ribbens, C., Kahn, M. F., & Malaise, M. (1997). Sarcoidosis: recognition and treatment guidelines. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 7 (6), 441-447. doi:10.2165/00063030-199707060-00003 |
Kaye, O., Ribbens, C., Hauwaert, C., & Malaise, M. (1995). Le méthotrexate en rhumatologie: une révolution thérapeutique. Revue Médicale de Liège, 50 (11), 453-457. |